371 related articles for article (PubMed ID: 27733129)
1. Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development.
Williamson DA; Smeesters PR; Steer AC; Morgan J; Davies M; Carter P; Upton A; Tong SY; Fraser J; Moreland NJ
BMC Infect Dis; 2016 Oct; 16(1):561. PubMed ID: 27733129
[TBL] [Abstract][Full Text] [Related]
2. Concerns for efficacy of a 30-valent M-protein-based Streptococcus pyogenes vaccine in regions with high rates of rheumatic heart disease.
Giffard PM; Tong SYC; Holt DC; Ralph AP; Currie BJ
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007511. PubMed ID: 31269021
[TBL] [Abstract][Full Text] [Related]
3. Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.
Shulman ST; Tanz RR; Dale JB; Beall B; Kabat W; Kabat K; Cederlund E; Patel D; Rippe J; Li Z; Sakota V;
Clin Infect Dis; 2009 Jul; 49(1):78-84. PubMed ID: 19480575
[TBL] [Abstract][Full Text] [Related]
4. Potential coverage of a multivalent M protein-based group A streptococcal vaccine.
Dale JB; Penfound TA; Tamboura B; Sow SO; Nataro JP; Tapia M; Kotloff KL
Vaccine; 2013 Mar; 31(12):1576-81. PubMed ID: 23375817
[TBL] [Abstract][Full Text] [Related]
5. Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage.
Engel ME; Muhamed B; Whitelaw AC; Musvosvi M; Mayosi BM; Dale JB
Pediatr Infect Dis J; 2014 Feb; 33(2):208-10. PubMed ID: 23934204
[TBL] [Abstract][Full Text] [Related]
6. Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece.
Syrogiannopoulos GA; Grivea IN; Al-Lahham A; Panagiotou M; Tsantouli AG; Michoula Ralf René Reinert AN; van der Linden M
PLoS One; 2013; 8(8):e71558. PubMed ID: 23977078
[TBL] [Abstract][Full Text] [Related]
7. Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape.
Smeesters PR; Vergison A; Campos D; de Aguiar E; Miendje Deyi VY; Van Melderen L
PLoS One; 2006 Dec; 1(1):e10. PubMed ID: 17183632
[TBL] [Abstract][Full Text] [Related]
8. Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal
Salie T; Engel K; Moloi A; Muhamed B; Dale JB; Engel ME
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669471
[TBL] [Abstract][Full Text] [Related]
9. Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population.
Gupta VK; Sekhar S; Dhanda V; Toor D; Kumar R; Chakraborti A
J Microbiol Immunol Infect; 2016 Jun; 49(3):352-8. PubMed ID: 25087198
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterisation of group A streptococcus isolates recovered from the north-west of Pretoria, South Africa.
Khosa XV; Kgasha O; Mabuza H; Moshe M; Engel K; Nchabeleng M
S Afr Med J; 2021 Apr; 111(5):487-490. PubMed ID: 34852893
[TBL] [Abstract][Full Text] [Related]
11. The emm-cluster typing system for Group A Streptococcus identifies epidemiologic similarities across the Pacific region.
Baroux N; D'Ortenzio E; Amédéo N; Baker C; Ali Alsuwayyid B; Dupont-Rouzeyrol M; O'Connor O; Steer A; Smeesters PR
Clin Infect Dis; 2014 Oct; 59(7):e84-92. PubMed ID: 24965347
[TBL] [Abstract][Full Text] [Related]
12. [Distribution of emm genotypes and antibiotic susceptibility of Streptococcus pyogenes strains: analogy with the vaccine in development].
Arslan U; Oryaşın E; Eskin Z; Türk Dağı H; Fındık D; Tuncer I; Bozdoğan B
Mikrobiyol Bul; 2013 Apr; 47(2):318-23. PubMed ID: 23621731
[TBL] [Abstract][Full Text] [Related]
13. Prospective surveillance of streptococcal sore throat in a tropical country.
Steer AC; Jenney AW; Kado J; Good MF; Batzloff M; Magor G; Ritika R; Mulholland KE; Carapetis JR
Pediatr Infect Dis J; 2009 Jun; 28(6):477-82. PubMed ID: 19483515
[TBL] [Abstract][Full Text] [Related]
14. M-Protein Analysis of Streptococcus pyogenes Isolates Associated with Acute Rheumatic Fever in New Zealand.
Williamson DA; Smeesters PR; Steer AC; Steemson JD; Ng AC; Proft T; Fraser JD; Baker MG; Morgan J; Carter PE; Moreland NJ
J Clin Microbiol; 2015 Nov; 53(11):3618-20. PubMed ID: 26292296
[TBL] [Abstract][Full Text] [Related]
15. Molecular biology of Group A
Brahmadathan NK
Indian J Med Microbiol; 2017; 35(2):176-183. PubMed ID: 28681803
[TBL] [Abstract][Full Text] [Related]
16. The emm-type diversity does not always reflect the M protein genetic diversity--is there a case for designer vaccine against GAS.
Smeesters PR; Dramaix M; Van Melderen L
Vaccine; 2010 Jan; 28(4):883-5. PubMed ID: 19963033
[No Abstract] [Full Text] [Related]
17. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002.
Shulman ST; Tanz RR; Kabat W; Kabat K; Cederlund E; Patel D; Li Z; Sakota V; Dale JB; Beall B;
Clin Infect Dis; 2004 Aug; 39(3):325-32. PubMed ID: 15306998
[TBL] [Abstract][Full Text] [Related]
18. Group A streptococcal meningitis: emm type distribution and theoretical vaccine coverage in children.
Tuerlinckx D; Gueulette E; Loens K; Goossens H; Smeesters PR
Acta Clin Belg; 2016 Jun; 71(3):138-41. PubMed ID: 26319426
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of group A streptococcus from pharyngeal isolates in Auckland, New Zealand, 2013.
Williamson DA; Moreland NJ; Carter P; Upton A; Morgan J; Proft T; Lennon D; Baker MG; Dunbar R; Fraser JD
N Z Med J; 2014 Jan; 127(1388):55-60. PubMed ID: 24481387
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of emm types, superantigen gene profiles and antibiotic resistance genes among Streptococcus pyogenes isolates from ocular infections, pharyngitis and asymptomatic children in south India.
Balaji K; Thenmozhi R; Prajna L; Dhananjeyan G; Pandian SK
Infect Genet Evol; 2013 Oct; 19():105-12. PubMed ID: 23851012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
